M. Miller Baker focuses his practice on complex civil litigation and serves as co-chair of the Firm’s Appellate Practice Group. Miller’s litigation experience includes matters involving constitutional law, preemption, health care, patents and intellectual property, energy, environmental law, election law, securities and white collar defense, food and beverage, the False Claims Act, the Federal Arbitration Act, administrative law, antitrust, employee benefits, agro-business, insurance, international trade, federal tax, and state and local tax.
As an appellate lawyer, Miller has argued before the US Supreme Court (three times, winning each time), nine of the thirteen federal courts of appeals, state appellate courts in Florida, New York, and Maryland, and the District of Columbia Court of Appeals.
As a trial lawyer, Miller has litigated in state and federal trial courts in seventeen states and the District of Columbia.
Miller served previously as Counsel to Senator Orrin Hatch on the Senate Judiciary Committee. During the final two years of the Reagan Administration, Miller served in the US Department of Justice, first as an Attorney-Advisor in the Office of Legal Policy and later as Special Assistant to the Assistant Attorney General for Civil Rights. Miller also served as an intelligence officer in the US Naval Reserve and as a law clerk to a federal appeals court judge and a federal district court judge.
Miller has appeared on CNN, National Public Radio, FOX Business News, Bloomberg Television, and numerous other radio and television news shows around the country and has been quoted in leading newspapers and journals in connection with constitutional matters. In the wake of 9/11, he testified on constitutional and policy issues pertaining to continuity of government before the House and Senate Judiciary Committees, as well as the bipartisan Continuity in Government Commission, a joint undertaking of the Brookings Institution and the American Enterprise Institute.
Healthcare Distribution Alliance v. Zucker, No. 1:18-cv-06168-KPF, 2018 WL 6651682 (S.D.N.Y. Dec. 19, 2018) (lead counsel for national trade association for pharmaceutical distributors in successful constitutional challenge to New York’s $600 million surcharge on manufacturers and distributors of opioid products)
Atkins v. CGI Techs. & Sols. Inc., No. 17-5506, 2018 WL 798393 (6th Cir. Feb. 9, 2018) (holding that Kentucky law did not “reverse preempt” the Federal Arbitration Act by operation of the McCarran-Ferguson Act)
Pharmaceutical Care Management Association v. Gerhart, 852 F.3d 722 (8th Cir. 2017) (holding that ERISA preempted Iowa law regulating the pharmacy benefit management function of ERISA plans)
In re BRCA1- and BRCA2-Based Hereditary CancerTest Patent Litigation, 774 F.3d 755 (Fed. Cir. 2014) (holding certain patent claims to be patent-ineligible)
Liberty Mutual Insurance Co. v. Donegan, 746 F.3d 497 (2d Cir. 2014) (holding that ERISA preempted Vermont law mandating claims data reporting by ERISA-governed health plans), aff’d, Gobeille v. Liberty Mutual Insurance Co., 136 S. Ct. 936 (2016)
Arthur Andersen, LLP v. Carlisle, 556 U.S. 624 (2009) (holding that the arbitration rights of non-signatories to an arbitration agreement are determined by reference to state law)
Courts / Agencies
Supreme Court of the United States
US Courts of Appeals, All Circuits
US District Court for the District of Columbia
US District Court for the Eastern District of Virginia
US District Court for the Western District of Virginia
US District Court for the Western District of Louisiana
US District Court for the Middle District of Louisiana
US Court of Federal Claims
US Court of International Trade
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.